30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

AgeX Therapeutics Inc (AGE)

Track

In the last 90 days, AgeX Therapeutics Inc. saw a net sell-off of insider shares, with total sales exceeding total purchases. Notably, Chief Scientific Officer Randall engaged in multiple sell transactions. Conversely, Karen J. Wilson and Richard Peter Marshall made several buy transactions during the same period.
Stock chart
Ticker: AGE Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
WILSON KAREN J
1 purchase — total 100,000 USD
Buy 12 Jun 2026
Value US$1,441,645.27 | Price 480.38 | Shares 17,987
Buy 11 Jun 2026
Value US$4,692,815.53 | Price 434.22 | Shares 74,767
Buy 22 May 2026
Value US$19,300.00 | Price 1.93 | Shares 10,000
Buy 21 May 2026
Value US$17,700.00 | Price 1.77 | Shares 10,000
Buy 19 May 2026
Value US$20,101.95 | Price 1.65 | Shares 12,183
Sale 23 Mar 2026
Value US$18,567.90 | Price 2.86 | Shares 6,500
Sale 19 Mar 2026
Value US$97,500.00 | Price 2.50 | Shares 39,000
Sale 2 Feb 2026
Value US$19,680.05 | Price 3.03 | Shares 6,500
Sale 2 Feb 2026
Value US$19,680.05 | Price 3.03 | Shares 6,500
Sale 28 Jan 2026
Value US$23,185.50 | Price 3.57 | Shares 6,500
Sale 22 Jan 2026
Value US$7,375.00 | Price 2.95 | Shares 2,500
Sale 21 Jan 2026
Value US$6,000.00 | Price 3.00 | Shares 2,000
Sale 20 Jan 2026
Value US$6,140.00 | Price 3.07 | Shares 2,000
Proposed sale 20 Jan 2026
Value US$279,370.00 | Price 3.07 | Shares 91,000
Sale 14 Jan 2026
Value US$2,713.36 | Price 2.50 | Shares 1,084
Sale 13 Jan 2026
Value US$13,540.00 | Price 2.50 | Shares 5,416
Sale 8 Jan 2026
Value US$34,953.10 | Price 2.69 | Shares 13,000
Sale 23 Dec 2025
Value US$10,660.00 | Price 2.60 | Shares 4,100
Sale 22 Dec 2025
Value US$15,167.90 | Price 2.67 | Shares 5,673
Sale 16 Dec 2025
Value US$9,561.92 | Price 2.96 | Shares 3,227
Sale 12 Dec 2025
Value US$5,541.49 | Price 3.26 | Shares 1,700
Sale 11 Dec 2025
Value US$11,519.62 | Price 3.24 | Shares 3,555
Sale 10 Dec 2025
Value US$2,160.75 | Price 3.35 | Shares 645
Sale 9 Dec 2025
Value US$1,987.98 | Price 3.31 | Shares 600
Sale 3 Dec 2025
Value US$17,623.00 | Price 3.52 | Shares 5,000
Sale 2 Dec 2025
Value US$5,857.80 | Price 3.91 | Shares 1,500
Sale 25 Nov 2025
Value US$23,264.10 | Price 3.90 | Shares 5,965
Sale 24 Nov 2025
Value US$2,105.22 | Price 3.94 | Shares 535
Sale 18 Nov 2025
Value US$24,401.65 | Price 3.75 | Shares 6,500
Sale 10 Nov 2025
Value US$26,650.00 | Price 4.10 | Shares 6,500
Sale 5 Nov 2025
Value US$14,407.52 | Price 4.24 | Shares 3,398
Sale 4 Nov 2025
Value US$13,634.22 | Price 4.40 | Shares 3,102
Sale 28 Oct 2025
Value US$27,541.29 | Price 4.96 | Shares 5,551
Sale 27 Oct 2025
Value US$4,921.23 | Price 5.19 | Shares 949
Sale 20 Oct 2025
Value US$32,286.80 | Price 4.97 | Shares 6,500
Proposed sale 13 Oct 2025
Value US$530,158.00 | Price 5.97 | Shares 88,826
Sale 13 Oct 2025
Value US$22,495.20 | Price 5.20 | Shares 4,326
Sale 26 Aug 2025
Value US$319,880.32 | Price 7.01 | Shares 45,632
Sale 25 Aug 2025
Value US$11,537.30 | Price 5.65 | Shares 2,042
Sale 20 Aug 2025
Value US$10,592.70 | Price 5.10 | Shares 2,077
Sale 18 Aug 2025
Value US$11,691.75 | Price 5.25 | Shares 2,227
Sale 12 Aug 2025
Value US$28,875.00 | Price 5.25 | Shares 5,500
Sale 4 Aug 2025
Value US$28,435.00 | Price 5.17 | Shares 5,500
Sale 29 Jul 2025
Value US$27,274.00 | Price 6.50 | Shares 4,196
Sale 28 Jul 2025
Value US$38,285.00 | Price 5.89 | Shares 6,500
Sale 21 Jul 2025
Value US$34,710.00 | Price 5.34 | Shares 6,500
Sale 14 Jul 2025
Value US$32,565.00 | Price 5.01 | Shares 6,500
Sale 7 Jul 2025
Value US$36,855.00 | Price 5.67 | Shares 6,500
Sale 30 Jun 2025
Value US$37,570.00 | Price 5.78 | Shares 6,500
Buy 17 Dec 2024
Value US$17,744.55 | Price 4.59 | Shares 3,866
Buy 20 Sep 2024
Value US$6,851.45 | Price 6.03 | Shares 1,137
Buy 19 Sep 2024
Value US$71,384.38 | Price 6.11 | Shares 11,679
Buy 18 Sep 2024
Value US$16,873.01 | Price 6.23 | Shares 2,709
Buy 12 Sep 2024
Value US$38,814.00 | Price 6.47 | Shares 6,000
Buy 20 Aug 2024
Value US$14,652.00 | Price 8.25 | Shares 1,776
Buy 19 Aug 2024
Value US$50,760.32 | Price 7.93 | Shares 6,400
Buy 16 Aug 2024
Value US$46,779.52 | Price 7.31 | Shares 6,400
Buy 15 Aug 2024
Value US$42,576.64 | Price 6.65 | Shares 6,400
Buy 15 Aug 2024
Value US$17,461.64 | Price 6.59 | Shares 2,650
Buy 15 Aug 2024
Value US$10,542.88 | Price 6.59 | Shares 1,600
Buy 15 Aug 2024
Value US$11,860.74 | Price 6.59 | Shares 1,800
Buy 15 Aug 2024
Value US$10,167.29 | Price 6.59 | Shares 1,543
Buy 15 Aug 2024
Value US$8,895.56 | Price 6.59 | Shares 1,350
Buy 14 Aug 2024
Value US$45,228.16 | Price 7.07 | Shares 6,400
Buy 25 Jun 2024
Value US$23,400.00 | Price 9.00 | Shares 2,600
Buy 21 Jun 2024
Value US$47,500.00 | Price 9.50 | Shares 5,000
Buy 30 May 2024
Value US$49,447.50 | Price 9.50 | Shares 5,205
Buy 29 May 2024
Value US$11,143.50 | Price 9.50 | Shares 1,173
Buy 28 May 2024
Value US$85,680.50 | Price 9.50 | Shares 9,019
Buy 23 May 2024
Value US$22,524.50 | Price 9.50 | Shares 2,371
Buy 21 May 2024
Value US$8,702.00 | Price 9.50 | Shares 916
Buy 21 May 2024
Value US$13,509.00 | Price 9.50 | Shares 1,422
Buy 21 May 2024
Value US$24,375.00 | Price 9.75 | Shares 2,500
Buy 21 May 2024
Value US$66,510.00 | Price 10.00 | Shares 6,651
Buy 20 May 2024
Value US$11,683.28 | Price 9.42 | Shares 1,240
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12 B Purchase
WILSON KAREN J
Non-Executive Director
17,987 +30.6%
480.38
US$1,441,645 		17,987 +30.6% 480.38 US$1,441,645
2026-06-15 2026-06-11 B Purchase
WILSON KAREN J
Non-Executive Director
74,767 +1.1%
434.22
US$4,692,816 		74,767 +1.1% 434.22 US$4,692,816
2026-05-26 2026-05-22 B Purchase
WILSON KAREN J
Non-Executive Director
61,376 -49.2%
435.19
US$3,183,365 		61,376 -49.2% 435.19 US$3,183,365
2026-05-26 2026-05-21 B Purchase
WILSON KAREN J
Non-Executive Director
10,000 +inf%
1.77
US$17,700 		10,000 +inf% 1.77 US$17,700
2026-05-22 2026-05-19 B Purchase
Marshall Richard Peter
Non-Executive Director
12,183 +inf%
1.65
US$20,102 		12,183 +inf% 1.65 US$20,102
2026-03-24 2026-03-23 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
2.86
US$18,568 		6,500 -100.0% 2.86 US$18,568
2026-03-20 2026-03-19 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
39,000 -100.0%
2.50
US$97,500 		39,000 -100.0% 2.50 US$97,500
2026-02-03 2026-02-02 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
3.03
US$19,680 		6,500 -100.0% 3.03 US$19,680
2026-02-03 2026-02-02 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
3.03
US$19,680 		6,500 -100.0% 3.03 US$19,680
2026-01-29 2026-01-28 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
3.57
US$23,186 		6,500 -100.0% 3.57 US$23,186
2026-01-23 2026-01-22 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
2,500 -100.0%
2.95
US$7,375 		2,500 -100.0% 2.95 US$7,375
2026-01-21 2026-01-21 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
2,000 -100.0%
3.00
US$6,000 		2,000 -100.0% 3.00 US$6,000
2026-01-21 2026-01-20 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
2,000 -100.0%
3.07
US$6,140 		2,000 -100.0% 3.07 US$6,140
2026-01-20 2026-01-20 PrS Proposed sale
Moreadith Randall

Officer

Officer
91,000
3.07
US$279,370 		91,000 3.07 US$279,370
2026-01-14 2026-01-14 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
1,084 -100.0%
2.50
US$2,713 		1,084 -100.0% 2.50 US$2,713
2026-01-14 2026-01-13 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
5,416 -100.0%
2.50
US$13,540 		5,416 -100.0% 2.50 US$13,540
2026-01-09 2026-01-08 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
13,000 -100.0%
2.69
US$34,953 		13,000 -100.0% 2.69 US$34,953
2025-12-29 2025-12-23 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
4,100 -100.0%
2.60
US$10,660 		4,100 -100.0% 2.60 US$10,660
2025-12-23 2025-12-22 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
5,673 -100.0%
2.67
US$15,168 		5,673 -100.0% 2.67 US$15,168
2025-12-17 2025-12-16 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
3,227 -100.0%
2.96
US$9,562 		3,227 -100.0% 2.96 US$9,562
2025-12-16 2025-12-12 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
1,700 -100.0%
3.26
US$5,541 		1,700 -100.0% 3.26 US$5,541
2025-12-12 2025-12-11 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
3,555 -100.0%
3.24
US$11,520 		3,555 -100.0% 3.24 US$11,520
2025-12-11 2025-12-10 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
645 -100.0%
3.35
US$2,161 		645 -100.0% 3.35 US$2,161
2025-12-11 2025-12-09 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
600 -100.0%
3.31
US$1,988 		600 -100.0% 3.31 US$1,988
2025-12-04 2025-12-03 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
5,000 -100.0%
3.52
US$17,623 		5,000 -100.0% 3.52 US$17,623
2025-12-04 2025-12-02 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
1,500 -100.0%
3.91
US$5,858 		1,500 -100.0% 3.91 US$5,858
2025-11-26 2025-11-25 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
5,965 -50.0%
3.90
US$23,264 		5,965 -50.0% 3.90 US$23,264
2025-11-25 2025-11-24 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
535 -100.0%
3.94
US$2,105 		535 -100.0% 3.94 US$2,105
2025-11-19 2025-11-18 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
3.75
US$24,402 		6,500 -100.0% 3.75 US$24,402
2025-11-12 2025-11-10 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
4.10
US$26,650 		6,500 -100.0% 4.10 US$26,650
2025-11-06 2025-11-05 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
3,398 -100.0%
4.24
US$14,408 		3,398 -100.0% 4.24 US$14,408
2025-11-05 2025-11-04 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
3,102 -100.0%
4.40
US$13,634 		3,102 -100.0% 4.40 US$13,634
2025-10-29 2025-10-28 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
5,551 -100.0%
4.96
US$27,541 		5,551 -100.0% 4.96 US$27,541
2025-10-28 2025-10-27 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
949 -100.0%
5.19
US$4,921 		949 -100.0% 5.19 US$4,921
2025-10-21 2025-10-20 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
4.97
US$32,287 		6,500 -100.0% 4.97 US$32,287
2025-10-14 2025-10-13 PrS Proposed sale
Moreadith Randall

Officer

Officer
88,826
5.97
US$530,158 		88,826 5.97 US$530,158
2025-10-14 2025-10-13 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
4,326 -100.0%
5.20
US$22,495 		4,326 -100.0% 5.20 US$22,495
2025-08-27 2025-08-26 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
45,632 -100.0%
7.01
US$319,880 		45,632 -100.0% 7.01 US$319,880
2025-08-27 2025-08-25 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
2,042 -100.0%
5.65
US$11,537 		2,042 -100.0% 5.65 US$11,537
2025-08-20 2025-08-20 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
2,077 -100.0%
5.10
US$10,593 		2,077 -100.0% 5.10 US$10,593
2025-08-20 2025-08-18 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
2,227 -100.0%
5.25
US$11,692 		2,227 -100.0% 5.25 US$11,692
2025-08-14 2025-08-12 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
5,500 -100.0%
5.25
US$28,875 		5,500 -100.0% 5.25 US$28,875
2025-08-06 2025-08-04 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
5,500 -100.0%
5.17
US$28,435 		5,500 -100.0% 5.17 US$28,435
2025-07-30 2025-07-29 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
4,196 -100.0%
6.50
US$27,274 		4,196 -100.0% 6.50 US$27,274
2025-07-29 2025-07-28 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
5.89
US$38,285 		6,500 -100.0% 5.89 US$38,285
2025-07-22 2025-07-21 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
5.34
US$34,710 		6,500 -100.0% 5.34 US$34,710
2025-07-17 2025-07-14 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
5.01
US$32,565 		6,500 -100.0% 5.01 US$32,565
2025-07-09 2025-07-07 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
5.67
US$36,855 		6,500 -100.0% 5.67 US$36,855
2025-07-02 2025-06-30 S Sale
Moreadith Randall

Chief Scientific Officer

Officer
6,500 -100.0%
5.78
US$37,570 		6,500 -100.0% 5.78 US$37,570
2024-12-19 2024-12-17 B Purchase
3.7
Bailey Gregory
Non-Executive Director
3,866 +6.1%
4.59
US$17,745 		3,866 +6.1% 4.59 US$17,745
2024-09-24 2024-09-20 B Purchase
3.7
Bailey Gregory
Non-Executive Director
1,137 +1.8%
6.03
US$6,851 		1,137 +1.8% 6.03 US$6,851
2024-09-20 2024-09-19 B Purchase
3.7
Bailey Gregory
Non-Executive Director
11,679 +23.1%
6.11
US$71,384 		11,679 +23.1% 6.11 US$71,384
2024-09-20 2024-09-18 B Purchase
3.7
Bailey Gregory
Non-Executive Director
2,709 +5.7%
6.23
US$16,873 		2,709 +5.7% 6.23 US$16,873
2024-09-16 2024-09-12 B Purchase
MINTZ STEVEN
Non-Executive Director
6,000 +52.4%
6.47
US$38,814 		6,000 +52.4% 6.47 US$38,814
2024-08-22 2024-08-20 B Purchase
3.7
Bailey Gregory
Non-Executive Director
1,776 +3.9%
8.25
US$14,652 		1,776 +3.9% 8.25 US$14,652
2024-08-20 2024-08-19 B Purchase
3.7
Bailey Gregory
Non-Executive Director
6,400 +16.2%
7.93
US$50,760 		6,400 +16.2% 7.93 US$50,760
2024-08-20 2024-08-16 B Purchase
3.7
Bailey Gregory
Non-Executive Director
6,400 +19.4%
7.31
US$46,780 		6,400 +19.4% 7.31 US$46,780
2024-08-20 2024-08-15 B Purchase
3.7
Bailey Gregory
Non-Executive Director
6,400 +24.1%
6.65
US$42,577 		6,400 +24.1% 6.65 US$42,577
2024-08-19 2024-08-15 B Purchase
MINTZ STEVEN
Non-Executive Director
2,650 +inf%
6.59
US$17,462 		2,650 +inf% 6.59 US$17,462
2024-08-19 2024-08-15 B Purchase
MINTZ STEVEN
Non-Executive Director
1,600 +129.0%
6.59
US$10,543 		1,600 +129.0% 6.59 US$10,543
2024-08-19 2024-08-15 B Purchase
MINTZ STEVEN
Non-Executive Director
1,800 +145.2%
6.59
US$11,861 		1,800 +145.2% 6.59 US$11,861
2024-08-19 2024-08-15 B Purchase
MINTZ STEVEN
Non-Executive Director
1,543 +15.6%
6.59
US$10,167 		1,543 +15.6% 6.59 US$10,167
2024-08-19 2024-08-15 B Purchase
MINTZ STEVEN
Non-Executive Director
1,350 +12.4%
6.59
US$8,896 		1,350 +12.4% 6.59 US$8,896
2024-08-16 2024-08-14 B Purchase
3.7
Bailey Gregory
Non-Executive Director
6,400 +31.7%
7.07
US$45,228 		6,400 +31.7% 7.07 US$45,228
2024-06-27 2024-06-25 B Purchase
MINTZ STEVEN
Non-Executive Director
2,600 +31.3%
9.00
US$23,400 		2,600 +31.3% 9.00 US$23,400
2024-06-27 2024-06-21 B Purchase
MINTZ STEVEN
Non-Executive Director
5,000 +151.2%
9.50
US$47,500 		5,000 +151.2% 9.50 US$47,500
2024-05-31 2024-05-30 B Purchase
3.7
Bailey Gregory
Non-Executive Director
5,205 +34.7%
9.50
US$49,448 		5,205 +34.7% 9.50 US$49,448
2024-05-31 2024-05-29 B Purchase
3.7
Bailey Gregory
Non-Executive Director
1,173 +8.5%
9.50
US$11,144 		1,173 +8.5% 9.50 US$11,144
2024-05-29 2024-05-28 B Purchase
3.7
Bailey Gregory
Non-Executive Director
9,019 +187.5%
9.50
US$85,680 		9,019 +187.5% 9.50 US$85,680
2024-05-24 2024-05-23 B Purchase
3.7
Bailey Gregory
Non-Executive Director
2,371 +97.3%
9.50
US$22,524 		2,371 +97.3% 9.50 US$22,524
2024-05-24 2024-05-21 B Purchase
3.7
Bailey Gregory
Non-Executive Director
916 +60.2%
9.50
US$8,702 		916 +60.2% 9.50 US$8,702
2024-05-23 2024-05-21 B Purchase
3.7
Bailey Gregory
Non-Executive Director
1,422 +1422.0%
9.50
US$13,509 		1,422 +1422.0% 9.50 US$13,509
2024-05-23 2024-05-21 B Purchase
MINTZ STEVEN
Non-Executive Director
2,500 +33.8%
9.75
US$24,375 		2,500 +33.8% 9.75 US$24,375
2024-05-23 2024-05-21 B Purchase
MINTZ STEVEN
Non-Executive Director
6,651 +888.0%
10.00
US$66,510 		6,651 +888.0% 10.00 US$66,510
2024-05-23 2024-05-20 B Purchase
MINTZ STEVEN
Non-Executive Director
1,240 +inf%
9.42
US$11,683 		1,240 +inf% 9.42 US$11,683
Explore more

More insider trading research around AgeX Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America